Trilogy Capital’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
Trilogy Capital's CAH Position: Q2 2026 in Review
Trilogy Capital reduced its Cardinal Health (CAH) stake by 9.5% in Q2 2026, selling an estimated $38K and leaving 1,737 shares worth $413K. The position accounts for 0.02% of the portfolio, ranked #290.
Trilogy Capital first reported a position in CAH in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.2M in Q4 2022. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Trilogy Capital held 1,737 shares of Cardinal Health worth $413K as of Q2 2026.
- Trilogy Capital sold 183 Cardinal Health shares in Q2 2026, an estimated $38K.
- Cardinal Health made up 0.02% of Trilogy Capital's portfolio in Q2 2026, its #290 holding.
- Trilogy Capital first reported a position in Cardinal Health in Q1 2018 and has held it in 17 quarters since.
- Trilogy Capital's Cardinal Health position peaked at $2.2M in Q4 2022.
- 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.